The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver Disease

The Effect of Oral β- Glucan Supplement on Anthropometric Measurements, Appetite, Insulin Resistance, Liver Echogenicity and Enzymes in Non Alcoholic Fatty Liver Disease Treating With Hypocaloric Diet and Vitamin E

The Objective of This Study is Evaluating the Effect of oral β- glucan Supplement on Anthropometric Measurements, Appetite, Insulin Resistance, Liver echogenicity and Enzymes in Non Alcoholic Fatty Liver Patients Treating with Hypocaloric Diet and Vitamin E.

Inclusion Criteria:

• Patients with Non Alcoholic Fatty Liver Disease From Both Sex
• Age 18-55 years
• BMI more than 25 Kg/m2

Exclusion Criteria:

• Alcohol Consumption
• Pregnancy or lactation or menopause
• Being a professional athlete
• A history of cancer
• Risk of high blood pressure (in the case of drug use)
• Heart disease - cardiovascular, pulmonary, renal and diabetes
• Liver transplantation and other chronic or acute Liver diseases such as hepatitis B, C and liver infections
• The History of inherited disorders affecting the liver
• A history of autoimmune disease
• History of food allergies
• Taking certain medications such as blood pressure control, statins, insulin sensitivity enhancers and hepatotoxic drugs